Health Sciences

The backlog in mammograms during the COVID-19 pandemic

The backlog of diagnostic mammograms is not expected to return to regular operations for nearly six months at best, and a lack of early detection will have health implications on cancer management for years to come.

From Penn LDI



In the News


NPR

Current, deadly U.S. coronavirus surge has peaked, researchers say

David Rubin of the Perelman School of Medicine and Children’s Hospital of Philadelphia said that while there’s been a decline in COVID-19 transmission rates in most parts of the country, it will take many weeks or months for the number of people getting sick and dying to fall. "It's going to take a while. There's going to be a long tail, unfortunately," he said.

FULL STORY →



The Washington Post

Some COVID-19 mutations may dampen vaccine effectiveness

E. John Wherry and Drew Weissman of the Perelman School of Medicine spoke about how new variants of the novel coronavirus might respond to the existing COVID-19 vaccines. “We don’t want people thinking that the current vaccine is already outdated. That’s absolutely not true,” said Wherry. However, he warned, the mutations “do in fact reduce how well our immune response is recognizing the virus.”

FULL STORY →



The New York Times

Underselling the vaccine

Aaron Richterman of the Perelman School of Medicine said overemphasizing the COVID-19 vaccine’s imperfections and unknowns may do more harm than good. “Not being completely open because you want to achieve some sort of behavioral public health goal—people will see through that eventually,” he said.

FULL STORY →



The New York Times

Need a new knee or hip? A robot may help install it

Matthew Sloan of the Perelman School of Medicine spoke about the increase in hip and knee replacement surgeries in the past 20 years. “Among the older patients, the big driver is the desire to stay active,” he said.

FULL STORY →



CBS Philadelphia

Drug being tested at University of Pennsylvania to treat COVID-19 shows promise

Carl June of the Perelman School of Medicine spoke about cyclosporin, an inexpensive drug that may help prevent severe inflammation in hospitalized COVID-19 patients. “Hopefully, [FDA approval of the drug] would decrease the burden of patients in our hospitals,” June said.

FULL STORY →